Expression of the third complement component (C3) and carboxypeptidase N small subunit (CPN1) during mouse embryonic development

Developmental and Comparative Immunology

Volumn 28, Issue 6, 2004, Pages 647-655

  Matthews, Kirstin W ^a,b   Drouin, Scott M ^a   Liu, Chengyu ^c   Martin, James F ^b,c   Skidgel, Randall A ^d   Wetsel, Rick A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Carboxypeptidase N; Complement; Embryos; Liver; Mouse development; Protease

Indexed keywords

ARGININE CARBOXYPEPTIDASE; COMPLEMENT COMPONENT C3; ISOENZYME; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME SUBUNIT; ERYTHROID PRECURSOR CELL; FEMALE; IN SITU HYBRIDIZATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RNA ANALYSIS;

EID: 1142285360     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2003.10.005     Document Type: Article

References (29)

1. Muller-Eberhard H.J. Molecular organization and function of complement. Ann Rev Biochem. 57:1988;321-347.
2. Goldstein I.M. Complement biologically active products. Gallin J.I., Goldstein I.M., Syderman R. Inflammation: basic principles and clinical correlates. 1992;Raven Press Ltd, New York.
3. Daffern P.J., Pfeifer P.H., Ember J.A., Hugli T.E. C3a is a chemotaxin for human eosinophils but not for neutrophils. I.C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med. 181:1995;2119-2127.
4. Nilsson G., Johnell M., Hammer C.H., Tiffany H.L., Nilsson K., Metcalfe D.D., Siegbahn A., Murphy P.M. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol. 157:1996;1693-1698.
5. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., Haase I., Lippert U., Zuberbier T. C3a and C5a stimulate chemotaxis of human mast cells. Blood. 89:1997;2863-2870.
6. Skidgel R.A. Human carboxypeptidase N: lysine carboxypeptidase. Methods Enzymol. 248:1995;653-663.
7. Bokisch V.A., Müller-Eberhard H.J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest. 49:1970;2427-2436.
8. Hsu M.H., Ember J.A., Wang M., Prossnitz E.R., Hugli T.E., Ye R.D. Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. Immunogenetics. 47:1997;64-72.
9. Wetsel R.A., Kildsgaard J., Haviland D.L. Complement anaphylatoxins (C3a, C4a,C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation. Lambris J.D., Holers V.M. Therapeutic interventions in the complement system. 2000;113-153 Humana Press, Totowa, NJ.
10. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science. 287:2000;498-501.
11. Levin Y., Skidgel R.A., Erdos E.G. Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase i). Proc Natl Acad Sci USA. 79:1982;4618-4622.
12. Matthews K.W., Wetsel R.A. Characterization of mouse carboxypeptidase N small active subunit gene structure. J Immunol. 166:2001;6196-6202.
13. Kawamura N., Singer L., Wetsel R.A., Colten H.R. Cis- and trans-acting elements required for constitutive and cytokine-regulated expression of the mouse complement C3 gene. Biochem J. 283:(Pt 3):1992;705-712.
14. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
16. Alper C.A., Johnson A.M., Birtch A.G., Moore F.D. Human C'3: evidence for the liver as the primary site of synthesis. Science. 163:1969;286-288.
17. Propp R.P., Alper C.A. C'3 synthesis in the human fetus and lack of transplacental passage. Science. 162:1968;672-673.
18. Rothman B., Despins A., Webb S., Taylor D., Sundarraj N., O'Rourke J., Kreutzer D. Cytokine regulation of C3 and C5 production by human corneal fibroblasts. Exp Eye Res. 53:1991;353-361.
19. Katz Y., Strunk R.C. Synovial fibroblast-like cells synthesize seven proteins of the complement system. Arthritis Rheum. 31:1988;1365-1370.
20. Welch T.R., Beischel L.S., Witte D.P. Differential expression of complement C3 and C4 in the human kidney. J Clin Invest. 92:1993;1451-1458.
21. Brooimans R.A., Stegmann A.P., van Dorp W.T., van der Ark A.A., van der Woude F.J., van Es L.A., Daha M.R. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest. 88:1991;379-384.
22. Ault B.H., Colten H.R. Cellular specificity of murine renal C3 expression in two models of inflammation. Immunology. 81:1994;655-660.
23. Choy L.N., Rosen B.S., Spiegelman B.M. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem. 267:1992;12736-12741.
24. White R.T., Damm D., Hancock N., Rosen B.S., Lowell B.B., Usher P., Flier J.S., Spiegelman B.M. Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 267:1992;9210-9213.
25. Circolo A., Garnier G., Fukuda W., Wang X., Hidvegi T., Szalai A.J., Briles D.E., Volanakis J.E., Wetsel R.A., Colten H.R. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology. 42:1999;135-149.
26. Li S.H., Huang H.L., Chen Y.H. Ovarian steroid-regulated synthesis and secretion of complement C3 and factor B in mouse endometrium during the natural estrous cycle and pregnancy period. Biol Reprod. 66:2002;322-332.
27. Erdos E. Erdos E. Handbook of experimental pharmacology. vol. 25:1979;427-487 Springer, Heidelberg.
28. Mizutani S., Goto K., Itakura A., Furuhashi M., Kurauchi O., Kikkawa F., Tomada Y. Physiological role of placental proteases: interaction between pregnancy-induced bioactive peptides and proteases. Endocrine J. 41:1994;S93-S104.
29. Skidgel R.A., Davis R.M., Tan F. Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem. 264:1989;2236-2241.